DE69801210T2 - Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern - Google Patents
Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von BlutgerinnungsfehlernInfo
- Publication number
- DE69801210T2 DE69801210T2 DE69801210T DE69801210T DE69801210T2 DE 69801210 T2 DE69801210 T2 DE 69801210T2 DE 69801210 T DE69801210 T DE 69801210T DE 69801210 T DE69801210 T DE 69801210T DE 69801210 T2 DE69801210 T2 DE 69801210T2
- Authority
- DE
- Germany
- Prior art keywords
- reagents
- coagulation
- conversion rate
- improved
- blood clotting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98105043A EP0947585B1 (de) | 1998-03-19 | 1998-03-19 | Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69801210D1 DE69801210D1 (de) | 2001-08-30 |
DE69801210T2 true DE69801210T2 (de) | 2002-05-02 |
Family
ID=8231624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69801210T Expired - Lifetime DE69801210T2 (de) | 1998-03-19 | 1998-03-19 | Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern |
Country Status (12)
Country | Link |
---|---|
US (4) | US6395501B1 (de) |
EP (1) | EP0947585B1 (de) |
AT (1) | ATE203567T1 (de) |
AU (2) | AU758831B2 (de) |
CA (1) | CA2334935C (de) |
DE (1) | DE69801210T2 (de) |
DK (1) | DK0947585T3 (de) |
ES (1) | ES2162361T3 (de) |
GR (1) | GR3036865T3 (de) |
NZ (1) | NZ506747A (de) |
PT (1) | PT947585E (de) |
WO (1) | WO1999047699A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6321164B1 (en) | 1995-06-07 | 2001-11-20 | Akzo Nobel N.V. | Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade |
US6898532B1 (en) | 1995-06-07 | 2005-05-24 | Biomerieux, Inc. | Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
US6429017B1 (en) * | 1999-02-04 | 2002-08-06 | Biomerieux | Method for predicting the presence of haemostatic dysfunction in a patient sample |
US6502040B2 (en) | 1997-12-31 | 2002-12-31 | Biomerieux, Inc. | Method for presenting thrombosis and hemostasis assay data |
ES2162361T3 (es) * | 1998-03-19 | 2001-12-16 | Instrumentation Lab Spa | Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea. |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US20030130185A1 (en) * | 2000-09-29 | 2003-07-10 | David Bar-Or | Metal-binding compounds and uses therefor |
US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US6743596B1 (en) * | 2000-10-27 | 2004-06-01 | Biomerieux, Inc. | Method of determining global coagulability hemostatic potential |
EP1260817A3 (de) | 2001-05-08 | 2002-12-18 | Warner-Lambert Company | Methode zur Direktbestimmung von Koagulationsfaktor VIIa in Plasma |
US20030055003A1 (en) * | 2001-07-19 | 2003-03-20 | David Bar-Or | Use of copper chelators to inhibit the inactivation of protein C |
US6902904B2 (en) * | 2001-08-27 | 2005-06-07 | Pharmanetics Incorporated | Coagulation assay reagents containing lanthanides |
EP1367135A1 (de) * | 2002-05-29 | 2003-12-03 | Pentapharm AG | Verbessertes Verfahren zur Beurteilung der Thrombinbildung in Blutplasma |
US20040091952A1 (en) * | 2002-07-25 | 2004-05-13 | Sysmex Corporation | Reagent kit for detecting lupus anticoagulant |
WO2005031303A2 (en) * | 2003-09-22 | 2005-04-07 | University Of North Carolina At Chapel Hill | Soluble phospholipids for use in clotting factor assays |
DE602005006633D1 (de) * | 2004-02-06 | 2008-06-26 | Sysmex Corp | Reagenziensatz zum Nachweis von Lupus-Antikoagulant. |
EP1833982B1 (de) * | 2005-01-07 | 2010-12-01 | Stichting Katholieke Universiteit | Blutstillungstest |
JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
JP4609177B2 (ja) * | 2005-04-28 | 2011-01-12 | チッソ株式会社 | カルシウム結合型発光蛋白質溶液の発光時間延長方法 |
US7957521B2 (en) * | 2005-11-30 | 2011-06-07 | On-Q Telecom Systems Co., Inc. | Method and system for user prioritization within telecommunication services and in particular within call completion services |
FR2908892B1 (fr) * | 2006-11-21 | 2009-02-20 | Hyphen Biomed Soc Par Actions | Procede pour le dosage chromogenique de l'activite du facteur viii:c et necessaire de dosage chromogenique de l'activite du facteur viii:c,dans les plasmas ou les fractions therapeutiques |
FR2909180B1 (fr) * | 2006-11-29 | 2009-02-20 | Diagnostica Stago Soc Par Acti | Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique. |
EP2313785B1 (de) * | 2008-08-05 | 2016-02-17 | Synapse B.V. | Verfahren und Vorrichtung zur Messung der Erzeugung von Thrombin in Plasma |
US9057574B2 (en) | 2012-06-14 | 2015-06-16 | Ra Brands, L.L.C. | Thumb safety for model 1911 handgun |
JP6577778B2 (ja) * | 2015-07-30 | 2019-09-18 | シスメックス株式会社 | 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット |
JP6595247B2 (ja) | 2015-07-30 | 2019-10-23 | シスメックス株式会社 | 凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット |
CN110568117B (zh) * | 2019-09-19 | 2022-03-22 | 青岛海洋生物医药研究院股份有限公司 | 一种多靶点抗血栓活性物质的液相色谱-质谱筛选方法 |
CN111707837A (zh) * | 2020-05-29 | 2020-09-25 | 上海太阳生物技术有限公司 | 狼疮抗凝物确认试剂盒(凝固法) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE203509C (de) * | ||||
DE3607559A1 (de) * | 1986-03-07 | 1987-09-10 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet |
US5055412A (en) * | 1989-03-21 | 1991-10-08 | Proksch Gary J | Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same |
SE464135B (sv) * | 1989-07-14 | 1991-03-11 | Kabivitrum Ab | Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov |
GB8927722D0 (en) * | 1989-12-07 | 1990-02-07 | British Bio Technology | Proteins and nucleic acids |
US5308756A (en) * | 1991-11-20 | 1994-05-03 | Baxter Diagnostics Inc. | Protein S chromogenic assay |
US5637452A (en) * | 1992-10-02 | 1997-06-10 | Analytical Control Systems, Inc. | Kit for an initial screen for abnormal platelet condition comprising propyl gallate or tannin and a metal ion |
DE4402631A1 (de) * | 1994-01-29 | 1995-08-03 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung von Gerinnungsparametern |
DK0756638T3 (da) * | 1994-04-22 | 2001-07-23 | Sanquin Bloedvoorziening | Midler til behandling af forstyrrelser i blodkoagulationskaskaden |
CA2288080C (en) * | 1997-04-25 | 2008-01-22 | Pentapharm Ag | Method for the functional detection of disorders in the protein c system |
DE19749197A1 (de) * | 1997-11-07 | 1999-05-12 | Dade Behring Marburg Gmbh | Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe |
AUPP159698A0 (en) * | 1998-02-02 | 1998-02-26 | Life Therapeutics Limited | Improved blood coagulation test |
US6245573B1 (en) * | 1998-02-12 | 2001-06-12 | University Of Medicine And Dentistry Of New Jersey | Rapid assessment of the coagulant activity of blood |
ES2162361T3 (es) | 1998-03-19 | 2001-12-16 | Instrumentation Lab Spa | Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea. |
US6743596B1 (en) * | 2000-10-27 | 2004-06-01 | Biomerieux, Inc. | Method of determining global coagulability hemostatic potential |
CA2440092A1 (en) * | 2001-03-02 | 2002-09-12 | T.A.C. Thrombosis And Coagulation Ab | Protein c variants |
US6902904B2 (en) * | 2001-08-27 | 2005-06-07 | Pharmanetics Incorporated | Coagulation assay reagents containing lanthanides |
-
1998
- 1998-03-19 ES ES98105043T patent/ES2162361T3/es not_active Expired - Lifetime
- 1998-03-19 DK DK98105043T patent/DK0947585T3/da active
- 1998-03-19 PT PT98105043T patent/PT947585E/pt unknown
- 1998-03-19 EP EP98105043A patent/EP0947585B1/de not_active Expired - Lifetime
- 1998-03-19 AT AT98105043T patent/ATE203567T1/de not_active IP Right Cessation
- 1998-03-19 DE DE69801210T patent/DE69801210T2/de not_active Expired - Lifetime
-
1999
- 1999-03-11 NZ NZ506747A patent/NZ506747A/xx unknown
- 1999-03-11 CA CA002334935A patent/CA2334935C/en not_active Expired - Fee Related
- 1999-03-11 AU AU30339/99A patent/AU758831B2/en not_active Ceased
- 1999-03-11 WO PCT/EP1999/001599 patent/WO1999047699A1/en active IP Right Grant
- 1999-03-19 US US09/273,413 patent/US6395501B1/en not_active Expired - Lifetime
-
2001
- 2001-10-11 GR GR20010401728T patent/GR3036865T3/el not_active IP Right Cessation
-
2002
- 2002-01-16 US US10/050,441 patent/US6730490B2/en not_active Expired - Lifetime
- 2002-12-30 US US10/331,731 patent/US6800450B2/en not_active Expired - Lifetime
-
2003
- 2003-07-03 AU AU2003212064A patent/AU2003212064B9/en not_active Ceased
-
2004
- 2004-05-28 US US10/856,108 patent/US7118880B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003212064B2 (en) | 2005-10-20 |
AU2003212064A1 (en) | 2003-08-14 |
US6730490B2 (en) | 2004-05-04 |
EP0947585B1 (de) | 2001-07-25 |
DE69801210D1 (de) | 2001-08-30 |
ATE203567T1 (de) | 2001-08-15 |
NZ506747A (en) | 2003-03-28 |
CA2334935A1 (en) | 1999-09-23 |
CA2334935C (en) | 2009-10-13 |
US6800450B2 (en) | 2004-10-05 |
PT947585E (pt) | 2001-11-30 |
AU2003212064B9 (en) | 2005-11-24 |
DK0947585T3 (da) | 2001-10-01 |
US20020115127A1 (en) | 2002-08-22 |
US20040235078A1 (en) | 2004-11-25 |
ES2162361T3 (es) | 2001-12-16 |
US20030199014A1 (en) | 2003-10-23 |
EP0947585A1 (de) | 1999-10-06 |
AU758831B2 (en) | 2003-04-03 |
US7118880B2 (en) | 2006-10-10 |
AU3033999A (en) | 1999-10-11 |
US6395501B1 (en) | 2002-05-28 |
WO1999047699A1 (en) | 1999-09-23 |
GR3036865T3 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69801210T2 (de) | Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern | |
DE502004008216D1 (de) | Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test | |
TWI256975B (en) | Compositions containing a urea derivative dye for detecting an analyte and methods for using the same | |
DE59813326D1 (de) | Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin | |
EP1221620A3 (de) | Verfahren zum Ausführen einer Bestimmung der "activated clotting time" mit geringer Empfindlichkeit gegenüber die Anwesenheit des Aprotinins sowie zur Ermittlung der Aprotinin-Empfindlichkeit | |
DK173090A (da) | Forbedrede ekstraktionsmetoder til fremstilling af thromboplastinreagenser | |
DE69610558T2 (de) | Test für thrombosegefahr | |
DE69411898D1 (de) | Neue antikoagulant-cofaktor aktivität | |
CA2162531A1 (en) | Method for specifically detecting a coagulation factor v which has an increased stability toward activated protein c in the activated state | |
ATE333091T1 (de) | Verfahren zur messung von blutersatzstoffen | |
Tan et al. | Comparison of the kinetic fibrinogen assay with the von Clauss method and the clot recovery method in plasma of patients with conditions affecting fibrinogen coagulability | |
DE60133510D1 (de) | Automatisches Verfahren zur quantitativen Bestimmung und Überwachung von exogenem Hämoglobin in Vollblut, Blutplasma und Blutserum | |
ES2107528T3 (es) | Ensayos de la actividad de la amilina. | |
DK0587090T3 (da) | Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer. | |
EP4253963A3 (de) | Klinisches entscheidungsunterstützungssystem | |
DE69520725T2 (de) | Verfahren zur Diagnose von Blutgerinnungsstörungen | |
DK0788595T3 (da) | Fremgangsmåde til undersögelse af immumkompetance | |
Tripodi | Activated protein C (APC) resistance | |
HUT60039A (en) | Method for detecting allergy to food proteins and screening test set applicable for said method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |